# WP-000-02 — Gate-00 Reassessment

**Evaluation state:** `DOCUMENTED_FOR_REVIEW`. **Gate-00 final status:** `BLOCKED_FOR_FORMAL_APPROVAL`.

| Criterion | Evidence | Verdict |
|---|---|---|
| Repo baseline intact, correct branch, no main modification | GitHub PR#1 commit history | VERIFIED_AT_REVIEW |
| Source conflict inventory | WP-000-01 AUTH-01..15 plus WP-000-02 RES-01..13 | PREPARED |
| Three missing parent docs | SOURCE_RECOVERY_LOG + SRC-EXC-001..003 (no originals) | UNRESOLVED |
| Migration obligations 20/20 | MIGRATION_DISPOSITION.csv | MAPPED_NOT_IMPLEMENTED |
| Legacy AG→new ENG semantics | LEGACY_AGENT_TO_ENGINE_MAP.md | PROPOSED |
| ADR-001/002/008/009/010 contract review | ADR_REVIEW_PACKAGE + revised draft ADRs | PENDING_HUMAN_APPROVAL |
| 64 feature/requirement IDs | Phase-00 Traceability crosswalk | COMPLETE_PLANNING_COVERAGE |
| 19 engine owner roles | Phase-00 ownership matrix | PERSON_UNASSIGNED |
| 120 Golden authored tests | DOC-018 + Library DOC-018 v1.2 | AUTHORED_NOT_EXECUTED |
| 16 frozen knowledge derivatives | KB-900 manifest | FILE_BYTES_NOT_REHASHED |
| Privacy/SOP/safety reviewer identity | REVIEW_AND_SIGNOFF | NOT_RECORDED |
| Documentation validation | GitHub Actions (separate verified run) | STRUCTURE_ONLY |

## Blocker dependency

`formal source recovery / signed source exceptions` + `ADR/product/safety/privacy/QA reviews` + `named accountable owners and rollback/risk controls` + `Gate signoff` ⇒ eligible for G-00 PASS; not before. Historical GPT-only V1 status is preserved and remains distinct from target platform.

## Next work

**WP-000-03:** named owner assignment; take each decision to relevant reviewer; obtain signed source exception or original versioned parents; review privacy and specialist SOP authority; attach review comments, versioned decisions and updated coverage records; revisit Gate-00. Do not merge PR #1 while Gate-00 remains BLOCKED unless a separately approved, explicitly scoped exception permits a documentation-only merge without implying contract approval.

## Explicit exclusions

No application source is written; no product integration, image benchmark, clinical/chemical trial, authorization test or Golden case has run. This record is not a release signoff.
